UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 1, 2015
Commission File No. 001-12575
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
| UTAH | 87-0342734 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
Registrant's telephone number: (801) 566-1200
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On May 1, 2015 at the annual meeting, shareholders of the Company approved or indicated their preference on the following matters submitted to them for consideration:
| | Elected Kevin L. Cornwell as a director of the Company: |
| | | For | 1,462,763 | Against | 93,673 | Abstentions | 1,421,464 |
| | | | | | | | |
| | Elected Paul O. Richins as a director of the Company: |
| | | For | 1,423,315 | Against | 99,473 | Abstentions | 1,455,112 |
| | | | | | | | |
| | Ratified the selection of Jones, Simkins P.C. as the Company’s independent public accounting firm for the year ended December 31, 2015: |
| | | For | 3,398,332 | Against | 19,045 | Abstentions | 14,634 |
| | | | | | | | |
| | Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: |
| | | For | 2,917,235 | Against | 45,240 | Abstentions | 15,425 |
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | UTAH MEDICAL PRODUCTS, INC. |
| | REGISTRANT |
| | |
| | |
Date: 5/04/2015 | By: /s/ Kevin L. Cornwell |
| | Kevin L. Cornwell |
| | CEO |
